The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
Open accessAbstract
Fifteen cases of hepatitis related to a combination of amoxycillin and clavulanic acid are reported. Most patients were aged 60 years or more and there were more men than women (sex ratio 4:1). The amoxycillin-clavulanic acid had been given at doses ranging from 0.5 to 6 g/day (mean 2 g/day) for seven to 60 days (mean 18 days). In 11 cases, the first symptoms appeared one to four weeks after stopping treatment. Jaundice was observed in all patients and was frequently associated with pruritus. Serum aminotransferase activities were increased in all patients and were generally two to 10 times the upper limit of normal. Serum alkaline phosphatase activity was considerably increased, from two to seven times the upper limit of normal. Histological examination of the liver, performed in seven patients, showed centri- or panlobular cholestasis in all cases, associated with granulomatous hepatitis in one. The prognosis of amoxycillin-clavulanic acid induced hepatitis seemed to be good. None of the patients exhibited biological or clinical features of hepatic failure and the course of the disease was characterised by the resolution of jaundice within one to eight weeks and a complete recovery within four to 16 weeks. Taking into account the number of treated subjects and reported cases, we estimated the risk of developing hepatitis with this drug combination to be very low, probably below 1/100,000. Our data suggest that the risk of hepatotoxicity may be increased in elderly men given lengthy treatment. The association of hepatitis and signs of hypersensitivity may suggest an immunoallergic mechanism of hepatotoxicity in some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Cited by
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Shirtliff, M. E., & Mader, J. T. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.527-544.2002 · Cited by 652
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Adverse drug reactions in elderly patients
Routledge, P. A., O'Mahony, M. S., & Woodhouse, K. W. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01875.x · Cited by 476
Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011) · Hepatology · doi:10.1002/hep.24229 · Cited by 387
Metadata
- Authors
- Larrey, D., Vial, T., Micaleff, A., Babany, G., Morichau-Beauchant, M., Michel, H., & Benhamou, J. P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1992-03
- Volume
- 33
- Issue
- 3
- Pages
- 368-371
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2046744217
- Cited by
- 190
- References
- 1
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. https://app.cochat.ai/papers/10.1136/gut.33.3.368
- The paper
- Larrey, D., Vial, T., Micaleff, A., Babany, G., Morichau-Beauchant, M., Michel, H., & Benhamou, J. P. (1992). Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut. https://doi.org/10.1136/gut.33.3.368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.